Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Schizophrenia, Bristol Myers Squibb
Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval
Key Takeaways Bristol Myers Squibb's drug to treat schizophrenia was approved for use by the Food and Drug Administration.The pharmaceutical firm called Cobenfy the first new treatment for the illness in decades.
New Era in Schizophrenia Care with Bristol Myers Squibb's COBENFY Approval
Highlights,Bristol Myers Squibb's shares rose following the FDA's approval of COBENFY, the first new schizophrenia treatment in decades.,The medication, a twice-daily pill, targets specific brain receptors and aims to reduce symptoms significantly.,This b...
The FDA just approved Bristol Myers Squibb's groundbreaking schizophrenia treatment
The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated schizophrenia drug, Cobenfy. It’s the first novel treatment for the debilitating mental disorder in over seven decades.
16m
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
Cobenfy (xanomeline and trospium chloride, KarXT), an oral medication for schizophrenia in adults. BMO Capital analyst notes ...
5h
on MSN
Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking.
Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This ...
3h
Bristol-Myers Squibb: Cobenfy Approval A Major Coup For The Dealmaker (Upgrade)
Bristol-Myers Squibb's acquisition of Karuna and FDA approval of Cobenfy signal growth potential, with focus on driving ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Promotes watch collection
Pleads not guilty
'Harry Potter' star dies
Stadiums to serve as shelters
World's oldest cheese found
Targeted Black residents?
Killer gets life sentence
50/50 ball ownership suit
Producing doc on Diddy
Ending password-sharing
Boxes to distribute Narcan
Urgent safety alert for 737s
Heads to US-Mexico border
Chinese submarine sank
WI duplicate ballot flap
NIH finds misconduct
Fake Biden robocalls fine
NC board removes 747K
On Secret Service failures
More executives leave
ISR targets Hezbollah HQ
US charges three Iranians
Capital goods orders up
Feedback